U.S. flag

An official website of the United States government

NM_001386393.1(PANK2):c.189_201del (p.Ala64fs) AND Pigmentary pallidal degeneration

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 9, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003613234.2

Allele description [Variation Report for NM_001386393.1(PANK2):c.189_201del (p.Ala64fs)]

NM_001386393.1(PANK2):c.189_201del (p.Ala64fs)

Genes:
LOC130065345:ATAC-STARR-seq lymphoblastoid silent region 12635 [Gene]
PANK2:pantothenate kinase 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
20p13
Genomic location:
Preferred name:
NM_001386393.1(PANK2):c.189_201del (p.Ala64fs)
HGVS:
  • NC_000020.11:g.3889619_3889631del
  • NG_008131.3:g.5781_5793del
  • NG_199762.1:g.448_460del
  • NM_001324191.2:c.-523_-511del
  • NM_001324192.1:c.519_531del
  • NM_001386393.1:c.189_201delMANE SELECT
  • NM_024960.6:c.-246+715_-246+727del
  • NM_153638.4:c.519_531del
  • NP_001311121.1:p.Ala174fs
  • NP_001373322.1:p.Ala64fs
  • NP_705902.2:p.Ala174fs
  • LRG_1016t1:c.519_531del
  • LRG_1016t2:c.189_201del
  • LRG_1016:g.5781_5793del
  • LRG_1016p1:p.Ala174fs
  • LRG_1016p2:p.Ala64fs
  • NC_000020.10:g.3870263_3870275del
  • NC_000020.10:g.3870266_3870278del
  • NR_136715.2:n.233_245del
Protein change:
A174fs
Molecular consequence:
  • NM_001324191.2:c.-523_-511del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001324192.1:c.519_531del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386393.1:c.189_201del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_153638.4:c.519_531del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_024960.6:c.-246+715_-246+727del - intron variant - [Sequence Ontology: SO:0001627]
  • NR_136715.2:n.233_245del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Pigmentary pallidal degeneration (NBIA1)
Synonyms:
PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET; Pantothenate kinase-associated neurodegeneration; Neuroaxonal dystrophy, late infantile; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009319; MedGen: C0018523; Orphanet: 157850; OMIM: 234200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004504448Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Mar 9, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ.

Nat Genet. 2001 Aug;28(4):345-9.

PubMed [citation]
PMID:
11479594

Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.

Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J.

N Engl J Med. 2003 Jan 2;348(1):33-40.

PubMed [citation]
PMID:
12510040
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004504448.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PANK2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala174Argfs*27) in the PANK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PANK2 are known to be pathogenic (PMID: 11479594, 12510040).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024